Use of molecular techniques to confirm true re-emergence of an original clone and to track minimal residual disease in acute lymphoblastic leukemia

Haematologica

Volumn 85, Issue 10, 2000, Pages 1102-1103

  Valetto, A ^a   Anselmi, A ^a   Scuderi, F ^a   Lanciotti, M ^a   Chiesa, V ^a   Dini, G ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Gene rearrangement; Late relapse; Leukemia; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER RECURRENCE; CASE REPORT; CHILD; CLONOGENESIS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LYMPHOBLASTOMA; MINIMAL RESIDUAL DISEASE; SCHOOL CHILD; T LYMPHOCYTE RECEPTOR GENE;

CHILD; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, LYMPHOBLASTIC; NEOPLASM, RESIDUAL; NEOPLASMS, SECOND PRIMARY; RECURRENCE;

EID: 0033763375     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Relapse of acute lymphoblastic leukaemia 14 years after presentation: Use of molecular techniques to confirm true re-emergence
2. Late relapse in a patient with acute lymphoblastic leukemia thirteen years after diagnosis
3. Clonal stability in late-relapsing childhood lymphoblastic leukaemia
4. Late relapsing childhood lymphoblastic leukemia
5. Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis
6. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia
7. Intensive BFM chemotherapy for childhood ALL: Interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica
8. Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: A 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP)
9. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
10. Molecular pathogenesis of childhood acute lymphoblastic leukemia